Find investors
← Back to all investors
AM
ResearchedAngel Investors

Arliadi Mahadi

Angel InvestorsSeed Round
Pitch Arliadi

Get their honest, personalized take on your startup.

Sign in to pitch Arliadi

At a glance

Full Name
Arliadi Mahadi
Firm
KV Asia Capital
Firm Type
Private equity
Investment Stage
Significant equity and control investments in mid-sized companies
Target Company Profile
Quality mid-sized companies, entrepreneurs, and management teams seeking business growth capital in Southeast Asia
Sector Focus
Consumer, healthcare, services, manufacturing, technology, logistics, industrials, education
Geographic Focus
Southeast Asia, including Indonesia, Malaysia, Singapore, Vietnam, the Philippines, and Thailand
Location
KV Asia Capital has offices/contact coverage in Singapore, Malaysia, Indonesia, Vietnam, Thailand, and the Philippines

Background

I could not independently verify a public biography, current title, LinkedIn profile, headshot, or direct public affiliation for Arliadi Mahadi. The supplied email domain points to KV Asia Capital, but KV Asia Capital’s public team pages do not list Arliadi Mahadi among the named team members available on the site.

KV Asia Capital describes itself as a private equity firm focused on making significant equity investments in quality mid-sized companies across Southeast Asia. The firm says its team has more than 200 years of collective experience across multiple business cycles and works with entrepreneurs and management teams to support growth and value creation.

The firm’s public materials indicate a regional private-equity strategy rather than seed-stage angel investing. Its disclosed transactions include significant equity and control investments, with portfolio companies across healthcare, cybersecurity, consumer, logistics, industrials, education, and services.

Investment Thesis & Focus

  • KV Asia Capital invests in Southeast Asian mid-sized companies where it can provide more than capital and act as a partner to entrepreneurs and management teams.
  • The firm’s stated investment philosophy is “Quality, Growth, Value.”
  • KV Asia Capital highlights underserved markets with growing demand, scalable businesses, need for capital, and limited global competition as investment rationale.
  • Target sectors include consumer, healthcare, services, manufacturing, business services, energy-related services, distribution and logistics, financial services, and healthcare services.
  • KV Asia Capital incorporates ESG factors into investment decisions, including environmental, social, and governance practices alongside financial performance.

Notable Investments

  • Kardia Indonesia Group - Integrated specialist healthcare and life-sciences group in Indonesia; significant equity investment in 2026; active.
  • i-Sprint Innovations - Singapore cybersecurity platform for identity, access management, mobile application protection, and post-quantum cryptography; control transaction in 2026; active.
  • ZUS Coffee - Tech-enabled grab-and-go coffee chain founded in Malaysia; significant equity investment in 2024; active.
  • Wildflour Hospitality Group - Premium casual restaurant operator in the Philippines; significant equity investment in 2024; active.
  • Bee Logistics - Vietnam-based integrated logistics company; significant equity investment in 2023; active.
  • G.B. Industries - Malaysia-based electrical PPE manufacturer; control transaction in 2022; active.
  • PT Victoria Care Indonesia Tbk - Indonesian beauty and personal care manufacturer and distributor; significant equity investment in 2021; active.
  • DXN Holdings - Malaysia-based health food supplements and direct-selling company; significant equity investment in 2017; exited.
  • Asia Pacific Education Holdings - Malaysian private education group; control transaction in 2017; exited.
  • TF Value Mart - Malaysian hypermarket chain; control transaction in 2016; exited.
  • Power Diesel - Singapore marine diesel engine inspection, maintenance, and repair provider; control transaction in 2015; exited.
  • Aalst Chocolate - Singapore chocolate manufacturer and exporter; significant equity investment in 2015; exited.
  • Orange Valley Healthcare - Singapore nursing-care provider; control transaction in 2014; exited.
  • DRx Group - Singapore medical aesthetics group; control transaction in 2014; exited.

Unlock the full research

Get how to approach them, recent activity, sources, contact links — plus pitch their AI twin for a candid read on your raise.

One-time. Stays unlocked for you.